Fresh analysis indicates that people who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a leading health publication demonstrates that while obese people often shed substantial amounts of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing such treatments must be cognizant of the potential of quick weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of regain suggests a reversion to starting mass within about a year and a half.
Weighing Treatments
The study, which reviewed dozens of studies involving thousands of participants, contrasted the outcomes of these new drugs with conventional dieting.
Scientists point out that people who shed pounds through dieting typically experience a more gradual creep back—perhaps 100 grams monthly—after stopping.
The Reason for the Fast Regain
Experts believe the way of the drugs accounts for the heightened regain.
The injections mimic a natural hormone called GLP-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to produce less of its own natural hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means appetite is uncontrolled, making excessive eating a significant risk."
A Lifelong Condition?
The NHS recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, due to the high risk of weight regain, the treatment should be considered long-term.
This view is reinforced by drug manufacturers, who state that the results "highlight the chronic character of excess weight," akin to managing diseases like diabetes.
Patient Accounts
Users who have stopped the medication explain a intense return of cravings.
"It was like a switch that goes on and you're instantly ravenous," described a patient.
The struggle is exacerbated if individuals have not developed sustainable lifestyle or habit modifications during treatment.
Growing Interest
Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is greater among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle management.
